â ‰ ¥

Related by string. * : â € € ™ . â € ~ . â € € . â € ¢ . â €  . ¢ â ¬  . â € œI . â € œThe . ¢ â ¬ â / : ‰ Ï Î ³ . ÎμÏ ‰ Ï Î . ‰ ¥ . ‰ Patrick McCreless . à ‰ . ‰ Approved . JOSà ‰ BORJà N . ‰ Approved request . ‰ Heard / : ¡ ¥ . ¥ #bn [002] . ¥ #bn [003] . ¥ #.#B [001] . ¥ #.#B [002] . ¥ #.#bn [001] . ¥ #B [002] . ¥ #B [001] * *

Related by context. Frequent words. (Click for all words.) 70 lymphopenia 70 % CI #.#-#.# [003] 70 % CI #.#-#.# [007] 69 leukopenia 69 sensory neuropathy 68 laboratory abnormalities 68 67 hypokalemia 67 febrile neutropenia 66 CI -#.# 66 P = .# 65 confidence interval #.#-#.# 65 acneform rash 65 p = .# [002] 65 % CI #.#-#.# [006] 64 esophagitis 64 hypocalcemia 64 rheumatoid factor 64 stomatitis 63 corticosteroid therapy 63 thrombocytopenia 63 μg kg 63 dyspareunia 63 mEq L 63 mg kg dose 63 Secondary endpoints 63 erythrocyte sedimentation rate 63 pheochromocytoma 63 ng dL 63 diarrhea nausea vomiting 62 hypomagnesemia 62 univariate analysis 62 Exclusion criteria 62 asthenia 62 mg BID 62 confidence interval CI 62 Postoperative 62 hematuria 62 μg L 62 Arch Intern Med 62 Secondary endpoints included 62 arthralgia 62 thromboembolic 62 pg ml 62 seronegative 62 HBsAg 61 mmol l 61 mg QD 61 CI #.#-#.# [002] 61 severe renal impairment 61 PsA 61 Neutropenia 61 nasopharyngitis 61 Psoriasis Area 61 chlorambucil 61 spinal cord compression 61 TAXUS p value 61 DOXIL 61 primary hypercholesterolemia 61 Asymptomatic 61 pericardial effusion 61 creatinine clearance 61 hypoglycemic events 61 plus methotrexate 61 hypercalcemia 61 Response Evaluation Criteria 61 pyrexia 61 pruritis 61 pg mL 60 sd = 60 daunorubicin 60 postop 60 events AEs 60 peripheral edema 60 μmol L 60 apolipoprotein B 60 cytogenetic response 60 tumor lysis syndrome 60 patients evaluable 60 Nephrol 60 virologic failure 60 IQR 60 J Natl Cancer Inst 60 J Clin Oncol 60 myalgia 60 pleural effusion 60 intramuscularly 60 #mg/day [001] 60 left ventricular systolic 60 ceftriaxone 60 EBRT 60 J Am Coll 60 mL kg 60 peginterferon alfa 2b 60 lispro 60 achieved statistical significance 60 postoperative nausea 59 dyspnea 59 Engerix B 59 renal insufficiency 59 hepatic encephalopathy

Back to home page